HER2-Positive Breast Cancer (PDF)

by Sara Hurvitz MD (Author), Kelly McCann (Author)
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.
Includes a timely section on innovative future therapies.

Product Details

• Paperback: 264 pages
• Publisher: Elsevier; 1 edition (August 30, 2018)
• Language: English
• ISBN-10: 0323581226
• ISBN-13: 978-0323581226
• Product Dimensions: 7.8 x 9.4 inches